"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"

NO_LONGER_AVAILABLE

Conditions studied: Primary Lateral Sclerosis, Adult, 1

In brief

This Individual Patient Expanded Access IND has been created as requested by an 83-year-old man who suffers Primary Lateral Sclerosis and for which the drugs currently approved are not providing an improvement over the progression of this disease.

Key facts

Study ID

NCT04825613

Run by

Hope Biosciences Research Foundation

Last updated by the study team

2025-09-29

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Adult individual at least 18 years old
• Clinical diagnosis Primary Lateral Sclerosis.
• Subject or Legal Authorized Representative has provided informed consent before initiation of any study procedure.
• Subject has mesenchymal stem cells banked at Hope Biosciences.

You may not qualify if…

• Clinically significant, uncontrolled cardiovascular, lung, renal, hepatic, or endocrine disease or any other acute or chronic medical condition that, in the opinion of the principal investigator, may increase the risks associated with study participation.
• Chemical or ETOH dependency that in the opinion of the investigator would preclude participation in the study.
• Participation in concurrent interventional research studies during this expanded access.
• Unwillingness to return for follow-up visits.

Where it is running

• Hope Biosciences Stem Cell Research Foundation — Sugar Land, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.